General Information of Drug Off-Target (DOT) (ID: OTPV69Q0)

DOT Name Small ribosomal subunit protein uS4 (RPS9)
Synonyms 40S ribosomal protein S9
Gene Name RPS9
Related Disease
Breast cancer ( )
Breast carcinoma ( )
Head and neck cancer ( )
Head and neck carcinoma ( )
Liver failure ( )
Neoplasm ( )
Bone osteosarcoma ( )
Osteosarcoma ( )
UniProt ID
RS9_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
PDB ID
4UG0 ; 4V6X ; 5A2Q ; 5AJ0 ; 5FLX ; 5LKS ; 5OA3 ; 5T2C ; 5VYC ; 6FEC ; 6G18 ; 6G4S ; 6G4W ; 6G51 ; 6G53 ; 6G5H ; 6G5I ; 6IP5 ; 6IP6 ; 6IP8 ; 6OLE ; 6OLF ; 6OLG ; 6OLI ; 6OLZ ; 6OM0 ; 6OM7 ; 6QZP ; 6XA1 ; 6Y0G ; 6Y2L ; 6Y57 ; 6YBW ; 6Z6L ; 6Z6M ; 6Z6N ; 6ZLW ; 6ZM7 ; 6ZME ; 6ZMI ; 6ZMO ; 6ZMT ; 6ZMW ; 6ZN5 ; 6ZOJ ; 6ZOK ; 6ZON ; 6ZP4 ; 6ZUO ; 6ZV6 ; 6ZVH ; 6ZVJ ; 6ZXD ; 6ZXE ; 6ZXF ; 6ZXG ; 6ZXH ; 7A09 ; 7K5I ; 7MQ8 ; 7MQ9 ; 7MQA ; 7QP6 ; 7QP7 ; 7R4X ; 7TQL ; 7WTS ; 7WTT ; 7WTU ; 7WTV ; 7WTW ; 7WTX ; 7WTZ ; 7WU0 ; 7XNX ; 7XNY ; 8G5Y ; 8G5Z ; 8G60 ; 8G61 ; 8G6J ; 8GLP ; 8JDJ ; 8JDK ; 8JDL ; 8JDM ; 8PPK ; 8PPL ; 8T4S
Pfam ID
PF00163 ; PF01479
Sequence
MPVARSWVCRKTYVTPRRPFEKSRLDQELKLIGEYGLRNKREVWRVKFTLAKIRKAAREL
LTLDEKDPRRLFEGNALLRRLVRIGVLDEGKMKLDYILGLKIEDFLERRLQTQVFKLGLA
KSIHHARVLIRQRHIRVRKQVVNIPSFIVRLDSQKHIDFSLRSPYGGGRPGRVKRKNAKK
GQGGAGAGDDEEED
Function
Component of the small ribosomal subunit. The ribosome is a large ribonucleoprotein complex responsible for the synthesis of proteins in the cell. Part of the small subunit (SSU) processome, first precursor of the small eukaryotic ribosomal subunit. During the assembly of the SSU processome in the nucleolus, many ribosome biogenesis factors, an RNA chaperone and ribosomal proteins associate with the nascent pre-rRNA and work in concert to generate RNA folding, modifications, rearrangements and cleavage as well as targeted degradation of pre-ribosomal RNA by the RNA exosome.
KEGG Pathway
Ribosome (hsa03010 )
Coro.virus disease - COVID-19 (hsa05171 )
Reactome Pathway
Peptide chain elongation (R-HSA-156902 )
SRP-dependent cotranslational protein targeting to membrane (R-HSA-1799339 )
Viral mRNA Translation (R-HSA-192823 )
Selenocysteine synthesis (R-HSA-2408557 )
rRNA modification in the nucleus and cytosol (R-HSA-6790901 )
Major pathway of rRNA processing in the nucleolus and cytosol (R-HSA-6791226 )
Translation initiation complex formation (R-HSA-72649 )
Formation of a pool of free 40S subunits (R-HSA-72689 )
Formation of the ternary complex, and subsequently, the 43S complex (R-HSA-72695 )
Ribosomal scanning and start codon recognition (R-HSA-72702 )
GTP hydrolysis and joining of the 60S ribosomal subunit (R-HSA-72706 )
Eukaryotic Translation Termination (R-HSA-72764 )
Regulation of expression of SLITs and ROBOs (R-HSA-9010553 )
Response of EIF2AK4 (GCN2) to amino acid deficiency (R-HSA-9633012 )
SARS-CoV-1 modulates host translation machinery (R-HSA-9735869 )
SARS-CoV-2 modulates host translation machinery (R-HSA-9754678 )
Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) (R-HSA-975956 )
Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) (R-HSA-975957 )
L13a-mediated translational silencing of Ceruloplasmin expression (R-HSA-156827 )

Molecular Interaction Atlas (MIA) of This DOT

8 Disease(s) Related to This DOT
Disease Name Disease ID Evidence Level Mode of Inheritance REF
Breast cancer DIS7DPX1 Strong Biomarker [1]
Breast carcinoma DIS2UE88 Strong Biomarker [1]
Head and neck cancer DISBPSQZ Strong Biomarker [2]
Head and neck carcinoma DISOU1DS Strong Biomarker [2]
Liver failure DISLGEL6 Strong Biomarker [3]
Neoplasm DISZKGEW Strong Biomarker [1]
Bone osteosarcoma DIST1004 Limited Altered Expression [4]
Osteosarcoma DISLQ7E2 Limited Altered Expression [4]
------------------------------------------------------------------------------------
⏷ Show the Full List of 8 Disease(s)
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
3 Drug(s) Affected the Post-Translational Modifications of This DOT
Drug Name Drug ID Highest Status Interaction REF
Valproate DMCFE9I Approved Valproate increases the methylation of Small ribosomal subunit protein uS4 (RPS9). [5]
Benzo(a)pyrene DMN7J43 Phase 1 Benzo(a)pyrene increases the methylation of Small ribosomal subunit protein uS4 (RPS9). [15]
Coumarin DM0N8ZM Investigative Coumarin decreases the phosphorylation of Small ribosomal subunit protein uS4 (RPS9). [17]
------------------------------------------------------------------------------------
10 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Estradiol DMUNTE3 Approved Estradiol decreases the expression of Small ribosomal subunit protein uS4 (RPS9). [6]
Ivermectin DMDBX5F Approved Ivermectin decreases the expression of Small ribosomal subunit protein uS4 (RPS9). [7]
Arsenic trioxide DM61TA4 Approved Arsenic trioxide decreases the expression of Small ribosomal subunit protein uS4 (RPS9). [8]
Hydrogen peroxide DM1NG5W Approved Hydrogen peroxide decreases the expression of Small ribosomal subunit protein uS4 (RPS9). [9]
Marinol DM70IK5 Approved Marinol decreases the expression of Small ribosomal subunit protein uS4 (RPS9). [10]
Zoledronate DMIXC7G Approved Zoledronate decreases the expression of Small ribosomal subunit protein uS4 (RPS9). [11]
Menthol DMG2KW7 Approved Menthol decreases the expression of Small ribosomal subunit protein uS4 (RPS9). [12]
Cocaine DMSOX7I Approved Cocaine decreases the expression of Small ribosomal subunit protein uS4 (RPS9). [13]
Bisphenol A DM2ZLD7 Investigative Bisphenol A increases the expression of Small ribosomal subunit protein uS4 (RPS9). [16]
chloropicrin DMSGBQA Investigative chloropicrin decreases the expression of Small ribosomal subunit protein uS4 (RPS9). [18]
------------------------------------------------------------------------------------
⏷ Show the Full List of 10 Drug(s)
1 Drug(s) Affected the Protein Interaction/Cellular Processes of This DOT
Drug Name Drug ID Highest Status Interaction REF
Dihydroartemisinin DMBXVMZ Approved Dihydroartemisinin affects the binding of Small ribosomal subunit protein uS4 (RPS9). [14]
------------------------------------------------------------------------------------

References

1 Gene expression profiling in women with breast cancer in a Saudi population.Saudi Med J. 2008 Apr;29(4):507-13.
2 Events of alternative splicing in head and neck cancer via RNA sequencing - an update.BMC Genomics. 2019 Jun 3;20(1):442. doi: 10.1186/s12864-019-5794-y.
3 Two-dimensional electrophoretic analysis of ribosomal proteins from chronically injured liver.J Clin Chem Clin Biochem. 1979 Aug;17(8):541-5. doi: 10.1515/cclm.1979.17.8.541.
4 Down-regulation of RPS9 Inhibits Osteosarcoma Cell Growth through Inactivation of MAPK Signaling Pathway.J Cancer. 2017 Aug 22;8(14):2720-2728. doi: 10.7150/jca.19130. eCollection 2017.
5 Integrative omics data analyses of repeated dose toxicity of valproic acid in vitro reveal new mechanisms of steatosis induction. Toxicology. 2018 Jan 15;393:160-170.
6 Genistein and bisphenol A exposure cause estrogen receptor 1 to bind thousands of sites in a cell type-specific manner. Genome Res. 2012 Nov;22(11):2153-62.
7 Quantitative proteomics reveals a broad-spectrum antiviral property of ivermectin, benefiting for COVID-19 treatment. J Cell Physiol. 2021 Apr;236(4):2959-2975. doi: 10.1002/jcp.30055. Epub 2020 Sep 22.
8 Proteomics-based identification of differentially abundant proteins from human keratinocytes exposed to arsenic trioxide. J Proteomics Bioinform. 2014 Jul;7(7):166-178.
9 Microarray analysis of H2O2-, HNE-, or tBH-treated ARPE-19 cells. Free Radic Biol Med. 2002 Nov 15;33(10):1419-32.
10 Cannabis-induced cytotoxicity in leukemic cell lines: the role of the cannabinoid receptors and the MAPK pathway. Blood. 2005 Feb 1;105(3):1214-21. doi: 10.1182/blood-2004-03-1182. Epub 2004 Sep 28.
11 The proapoptotic effect of zoledronic acid is independent of either the bone microenvironment or the intrinsic resistance to bortezomib of myeloma cells and is enhanced by the combination with arsenic trioxide. Exp Hematol. 2011 Jan;39(1):55-65.
12 Repurposing L-menthol for systems medicine and cancer therapeutics? L-menthol induces apoptosis through caspase 10 and by suppressing HSP90. OMICS. 2016 Jan;20(1):53-64.
13 Gene expression profile of the nucleus accumbens of human cocaine abusers: evidence for dysregulation of myelin. J Neurochem. 2004 Mar;88(5):1211-9. doi: 10.1046/j.1471-4159.2003.02247.x.
14 Untargeted Proteomics and Systems-Based Mechanistic Investigation of Artesunate in Human Bronchial Epithelial Cells. Chem Res Toxicol. 2015 Oct 19;28(10):1903-13. doi: 10.1021/acs.chemrestox.5b00105. Epub 2015 Sep 21.
15 Air pollution and DNA methylation alterations in lung cancer: A systematic and comparative study. Oncotarget. 2017 Jan 3;8(1):1369-1391. doi: 10.18632/oncotarget.13622.
16 Isobaric tags for relative and absolute quantitation-based proteomics analysis of the effect of ginger oil on bisphenol A-induced breast cancer cell proliferation. Oncol Lett. 2021 Feb;21(2):101. doi: 10.3892/ol.2020.12362. Epub 2020 Dec 8.
17 Quantitative phosphoproteomics reveal cellular responses from caffeine, coumarin and quercetin in treated HepG2 cells. Toxicol Appl Pharmacol. 2022 Aug 15;449:116110. doi: 10.1016/j.taap.2022.116110. Epub 2022 Jun 7.
18 Transcriptomic analysis of human primary bronchial epithelial cells after chloropicrin treatment. Chem Res Toxicol. 2015 Oct 19;28(10):1926-35.